| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.96▼ | 12.96▼ | 12.98▼ | 13.12▼ | 12.37▲ |
| MA10 | 13.00▼ | 13.12▼ | 13.24▼ | 12.97▼ | 11.76▲ |
| MA20 | 13.11▼ | 13.27▼ | 13.29▼ | 12.56▲ | 10.59▲ |
| MA50 | 13.27▼ | 13.17▼ | 13.03▼ | 11.64▲ | 12.65▲ |
| MA100 | 13.12▼ | 13.03▼ | 12.91▼ | 10.43▲ | 25.83▼ |
| MA200 | 13.01▼ | 12.47▲ | 11.89▲ | 11.13▲ | 57.24▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.019▼ | -0.073▼ | -0.084▼ | -0.025▼ | 0.651▲ |
| RSI | 31.456▼ | 34.614▼ | 39.098▼ | 54.624▲ | 53.894▲ |
| STOCH | 60.000 | 13.874▼ | 14.694▼ | 64.279 | 61.049 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -56.593 | -25.567 |
| CCI | -142.860▼ | -91.176 | -112.896▼ | -38.277 | 117.567▲ |
|
Tuesday, September 02, 2025 09:05 AM
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/25 | 13.25 | 13.25 | 12.72 | 12.72 | 31,853 |
| 24/09/25 | 13.36 | 13.75 | 13.275 | 13.45 | 42,218 |
| 23/09/25 | 13.04 | 13.48 | 13.04 | 13.18 | 61,111 |
| 22/09/25 | 13.13 | 13.52 | 12.90 | 13.17 | 163,105 |
| 19/09/25 | 12.70 | 13.22 | 12.70 | 13.09 | 279,289 |
| 18/09/25 | 12.42 | 12.76 | 12.36 | 12.64 | 53,238 |
| 17/09/25 | 12.77 | 13.18 | 11.93 | 12.31 | 158,415 |
| 16/09/25 | 12.85 | 13.615 | 12.4589 | 13.22 | 34,312 |
| 15/09/25 | 13.06 | 13.37 | 12.97 | 13.13 | 41,912 |
| 12/09/25 | 13.41 | 13.41 | 12.6799 | 12.82 | 32,402 |
|
|
||||
|
|
||||
|
|